Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mai Yamada

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Oncotarget|January 21, 2017
The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancerHitomi Mori, Makoto Kubo, Rin Yamaguchi, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 26, 2018
Detection of Autoreactive Type II NKT Cells: A Pilot Study of Comparison Between Healthy Individuals and Patients with VasculitisYusuke Nishioka, Takaomi Sonoda, Haruki Shida, et al.
Breast Cancer Research and Treatment|May 10, 2019
T-bet<sup>+</sup> lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancerHitomi Mori, Makoto Kubo, Masaya Kai, et al.
Plos One|December 16, 2016
BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast CancerHitomi Mori, Makoto Kubo, Reiki Nishimura, et al.
Scientific Reports|July 1, 2021
Neoantigens elicit T cell responses in breast cancerTakafumi Morisaki, Makoto Kubo, Masayo Umebayashi, et al.
Cancers|September 28, 2023
Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast CancerKimihisa Mizoguchi, Hitomi Kawaji, Masaya Kai, et al.
Cancer Medicine|January 16, 2021
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patientsKaren Zaguirre, Masaya Kai, Makoto Kubo, et al.
Cancer Medicine|December 4, 2020
Comprehensive molecular profiling broadens treatment options for breast cancer patientsHitomi Kawaji, Makoto Kubo, Nami Yamashita, et al.
Biomacromolecules|August 25, 2025
In Situ Ionically Cross-Linkable Benzaldehyde-Modified Alginate and Its Bilayer Structure as a Tissue Sealant for Dural ClosureI-Hsuan Yang, Natsuko F Inagaki, Arvind K Singh Chandel, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Oncotarget|January 21, 2017
The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancerHitomi Mori, Makoto Kubo, Rin Yamaguchi, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 26, 2018
Detection of Autoreactive Type II NKT Cells: A Pilot Study of Comparison Between Healthy Individuals and Patients with VasculitisYusuke Nishioka, Takaomi Sonoda, Haruki Shida, et al.
Breast Cancer Research and Treatment|May 10, 2019
T-bet<sup>+</sup> lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancerHitomi Mori, Makoto Kubo, Masaya Kai, et al.
Plos One|December 16, 2016
BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast CancerHitomi Mori, Makoto Kubo, Reiki Nishimura, et al.
Scientific Reports|July 1, 2021
Neoantigens elicit T cell responses in breast cancerTakafumi Morisaki, Makoto Kubo, Masayo Umebayashi, et al.
Cancers|September 28, 2023
Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast CancerKimihisa Mizoguchi, Hitomi Kawaji, Masaya Kai, et al.
Cancer Medicine|January 16, 2021
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patientsKaren Zaguirre, Masaya Kai, Makoto Kubo, et al.
Cancer Medicine|December 4, 2020
Comprehensive molecular profiling broadens treatment options for breast cancer patientsHitomi Kawaji, Makoto Kubo, Nami Yamashita, et al.
Biomacromolecules|August 25, 2025
In Situ Ionically Cross-Linkable Benzaldehyde-Modified Alginate and Its Bilayer Structure as a Tissue Sealant for Dural ClosureI-Hsuan Yang, Natsuko F Inagaki, Arvind K Singh Chandel, et al.
Pageof 5